1 Department of Pediatrics, VU University Medical Center, Amsterdam, the Netherlands.
2 Department of Oral and Maxillofacial Surgery, Academic Medical Center, Amsterdam, the Netherlands.
J Hum Lact. 2019 Feb;35(1):154-164. doi: 10.1177/0890334418775630. Epub 2018 Jul 3.
: Medication use during pregnancy and lactation can be unavoidable, but knowledge on safety for the fetus or breastfed infant is limited among patients and healthcare providers.
: This study aimed to determine (a) the prevalence of medication use in pregnant and lactating women in a tertiary academic center, (b) the types and safety of these medicines, and (c) the influence of medication use on initiation of breastfeeding.
: This study used a cross-sectional survey among women ( N = 292) who underwent high-risk or low-risk deliveries. Data about their use of prescribed, over-the-counter, and homeopathic medication during pregnancy were obtained through a structured interview, followed by a questionnaire during lactation. Safety was classified according to the risk classification system from the Dutch Teratological Information Service.
: Overall, 95.5% of participants used medication. One third of participants used at least one medicine with an unknown risk for the fetus. Teratogenic medication was used by 6.5% of participants, whereas 29.5% used medication with a (suspected) pharmacological effect on the fetus. Lactation was initiated by 258 (88.7%) participants, of which 84.2% used medication while breastfeeding. In 3.8% of participants, this medication was classified unsafe, but none used medication with an unknown risk. One-third of the nonlactating participants decided not to initiate breastfeeding because of medication use. In 70% of participants, this decision was appropriate.
: The prevalence of overall use of medication in Dutch pregnant and lactating women admitted to a tertiary center was high. There is an urgent need for pharmacometric studies for determination of the safe use of the most frequently used medicines during pregnancy or lactation.
在妊娠和哺乳期使用药物可能是不可避免的,但患者和医疗保健提供者对胎儿或母乳喂养婴儿的安全性知之甚少。
本研究旨在确定:(a)在一家三级学术中心妊娠和哺乳期妇女用药的流行率;(b)这些药物的类型和安全性;(c)用药对母乳喂养启动的影响。
本研究使用横断面调查,对在高危或低危分娩中心分娩的女性(N=292)进行调查。通过结构化访谈获得她们在妊娠期间使用处方、非处方和顺势疗法药物的数据,随后在哺乳期通过问卷调查。安全性根据荷兰致畸信息服务的风险分类系统进行分类。
总体而言,95.5%的参与者使用了药物。三分之一的参与者使用了至少一种对胎儿风险未知的药物。6.5%的参与者使用了致畸药物,而 29.5%的参与者使用了对胎儿有(疑似)药理作用的药物。258 名(88.7%)参与者开始母乳喂养,其中 84.2%的人在母乳喂养期间使用了药物。在 3.8%的参与者中,这种药物被归类为不安全,但没有使用风险未知的药物。三分之一的非哺乳期参与者因用药而决定不开始母乳喂养。在 70%的参与者中,这一决定是合适的。
在一家三级中心就诊的荷兰妊娠和哺乳期妇女总体用药流行率较高。迫切需要进行药代动力学研究,以确定在妊娠或哺乳期最常使用的药物的安全使用方法。